New combo attack on rectal cancer: shorter radiation vs. longer radiation before surgery
NCT ID NCT07284992
Summary
This study is testing whether a shorter, more intense course of radiation is as good as a longer, standard course when both are combined with a new immunotherapy drug and chemotherapy. The goal is to shrink tumors before surgery in people with locally advanced rectal cancer that hasn't spread. Researchers will compare how well the two approaches work and how safe they are.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shandong Provincial Hospital Affiliated to Shandong First Medical University
RECRUITINGJinan, Shandong, 250021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.